4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000002
10% owner bought 56,329 shares at an average $2.53 ($142,516)
From the SEC's structured data for this filing
Trades in this filing
Caissa Capital Management ltd. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-10 | Purchase : show line 1 in the form | +31,329 | $2.28 | $71,436 | 1,242,700 | I |
| 2023-04-11 | Purchase : show line 2 in the form | +25,000 | $2.84 | $71,080 | 1,267,700 | I |
| Open-market purchases · 56,329 sh · avg $2.53 · $142,516 | ||||||
Loading xslF345X04/primary_doc.xml…